Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

536 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myocardial Inflammation and Dysfunction in COVID-19-Associated Myocardial Injury.
Weckbach LT, Curta A, Bieber S, Kraechan A, Brado J, Hellmuth JC, Muenchhoff M, Scherer C, Schroeder I, Irlbeck M, Maurus S, Ricke J, Klingel K, Kääb S, Orban M, Massberg S, Hausleiter J, Grabmaier U. Weckbach LT, et al. Among authors: hausleiter j. Circ Cardiovasc Imaging. 2021 Jan;14(1):e012220. doi: 10.1161/CIRCIMAGING.120.011713. Epub 2021 Jan 19. Circ Cardiovasc Imaging. 2021. PMID: 33463366
Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.
Massberg S, Byrne RA, Kastrati A, Schulz S, Pache J, Hausleiter J, Ibrahim T, Fusaro M, Ott I, Schömig A, Laugwitz KL, Mehilli J; Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting Versus Zotarolimus- Eluting Stents (ISAR-TEST 5) Investigators. Massberg S, et al. Among authors: hausleiter j. Circulation. 2011 Aug 2;124(5):624-32. doi: 10.1161/CIRCULATIONAHA.111.026732. Epub 2011 Jul 18. Circulation. 2011. PMID: 21768546 Clinical Trial.
Extracorporal life support (ECLS) in acute ischaemic cardiogenic shock.
Sattler S, Khaladj N, Zaruba MM, Fischer M, Hausleiter J, Mehilli J, Kääb S, Hagl C, Massberg S, Theiss HD. Sattler S, et al. Among authors: hausleiter j. Int J Clin Pract. 2014 Apr;68(4):529-31. doi: 10.1111/ijcp.12380. Int J Clin Pract. 2014. PMID: 24674706 No abstract available.
Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry.
Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz KL, Sibbing D, Kastrati A. Orban M, et al. Among authors: hausleiter j. Thromb Haemost. 2014 Dec;112(6):1190-7. doi: 10.1160/TH14-06-0489. Epub 2014 Aug 28. Thromb Haemost. 2014. PMID: 25183544
Long-term outcome of patients with severe biventricular heart failure and severe mitral regurgitation after percutaneous edge-to-edge mitral valve repair.
Orban M, Braun D, Orban M, Grebmer C, Sibbing D, Thaler R, Tittus J, Wimbauer F, Lesevic H, Sonne C, Mehilli J, Ott I, Näbauer M, Massberg S, Boekstegers P, Hausleiter J. Orban M, et al. Among authors: hausleiter j. J Interv Cardiol. 2015 Apr;28(2):164-71. doi: 10.1111/joic.12193. Epub 2015 Apr 10. J Interv Cardiol. 2015. PMID: 25858050 Free article.
The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry.
Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, Mehilli J, Schunkert H, Massberg S, Laugwitz KL, Sibbing D, Kastrati A. Orban M, et al. Among authors: hausleiter j. Thromb Res. 2015 Jul;136(1):87-93. doi: 10.1016/j.thromres.2015.04.029. Epub 2015 Apr 30. Thromb Res. 2015. PMID: 25976448
536 results